Electrical conduction along endothelial cell tubes from mouse feed arteries: Confounding actions of glycyrrhetinic acid derivatives

Abstract

Background and Purpose: Electrical conduction along endothelium of resistance vessels has not been determined independently of the influence of smooth muscle, surrounding tissue or blood. Two interrelated hypotheses were tested: (i) Intercellular conduction of electrical signals is manifest in endothelial cell (EC) tubes; and (ii) Inhibitors of gap junction channels (GJCs) have confounding actions on EC electrical and Ca 2+ signalling. Experimental Approach: Intact EC tubes were isolated from abdominal muscle feed (superior epigastric) arteries of C57BL/6 mice. Hyperpolarization was initiated with indirect (ACh) and direct (NS309) stimulation of intermediate- and small-conductance Ca 2+-activated K + channels (IK Ca/SK Ca). Remote membrane potential (V m) responses to intracellular current injection defined the length constant (Î) for electrical conduction. Dye coupling was evaluated following intracellular microinjection of propidium iodide. Intracellular Ca 2+ dynamics were determined using Fura-2 photometry. Carbenoxolone (CBX) or β-glycyrrhetinic acid (βGA) was used to investigate the role of GJCs. Key Results: Steady-state V m of ECs was -25 mV. ACh and NS309 hyperpolarized ECs by -40 and -60 mV respectively. Electrical conduction decayed monoexponentially with distance (γ∼1.4 mm). Propidium iodide injected into one EC spread into surrounding ECs. CBX or βGA inhibited dye transfer, electrical conduction and EC hyperpolarization reversibly. Both agents elevated resting Ca 2+ while βGA inhibited responses to ACh. Conclusions and Implications: Individual cells were effectively coupled to each other within EC tubes. Inhibiting GJCs with glycyrrhetinic acid derivatives blocked hyperpolarization mediated by IK Ca/SK Ca channels, regardless of Ca 2+ signalling, obviating use of these agents in distinguishing key determinants of electrical conduction along the endothelium. © 2011 The British Pharmacological Society.